Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $48,616. The most recent transaction as insider was on Mar 15, 2024, when has been sold 15,000 shares (Common Stock) at a price of $129.49 per share, resulting in proceeds of $1,942,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130
0% 3M change
0% 12M change
Total Value Held $48,616

MARTINE A ROTHBLATT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 14 2024
SELL
Open market or private sale
$3,584,250 $238.95 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 14 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 13 2024
SELL
Open market or private sale
$3,666,000 $244.4 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 13 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 12 2024
SELL
Open market or private sale
$3,728,400 $248.56 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 12 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 11 2024
SELL
Open market or private sale
$3,711,450 $247.43 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 11 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 08 2024
SELL
Open market or private sale
$3,612,000 $240.8 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 08 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 07 2024
SELL
Open market or private sale
$3,601,050 $240.07 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 07 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 06 2024
SELL
Open market or private sale
$3,530,850 $235.39 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 06 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 05 2024
SELL
Open market or private sale
$1,457,316 $231.32 p/Share
6,300 Reduced 97.98%
130 Common Stock
Mar 05 2024
BUY
Exercise of conversion of derivative security
$815,787 $129.49 p/Share
6,300 Added 49.49%
6,430 Common Stock
Mar 04 2024
SELL
Open market or private sale
$211,904 $231.59 p/Share
915 Reduced 87.56%
130 Common Stock
Mar 04 2024
BUY
Exercise of conversion of derivative security
$118,483 $129.49 p/Share
915 Added 46.68%
1,045 Common Stock
Mar 01 2024
SELL
Open market or private sale
$3,512,550 $234.17 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
May 02 2023
SELL
Open market or private sale
$1,837,600 $229.7 p/Share
8,000 Reduced 98.4%
130 Common Stock
May 02 2023
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
May 01 2023
SELL
Open market or private sale
$1,850,880 $231.36 p/Share
8,000 Reduced 98.4%
130 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
MAR

Martine A Rothblatt

Chairperson & CEO
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR